The U.S. joined Japan in buying yen, helping reverse the currency's slide as authorities signaled that further coordinated action remained possible.

Japan and the ​United States conducted coordinated yen-buying intervention and will not hesitate to take further action, Japan's finance ministry said on Monday, confirming a rare bilateral action to halt the ‌yen's slide to fresh 40-year lows.

Japanese Finance Minister Satsuki Katayama is set to announce as early as Monday that Tokyo and Washington are coordinating on steps in the foreign exchange market to curb the yen’s weakness, a person familiar with the situation said.

Japan's Finance Ministry said Monday it conducted a coordinated yen-buying intervention with the U.S. Treasury on Friday.

U.S. stocks were on track to extend Friday’s rally as President Trump said he had canceled planned strikes on Iran, adding that peace talks would resume Monday afternoon.

Oil prices fell sharply Sunday after President Donald Trump said he would order U.S. forces to hold off on new strikes against Iran

The yield on the 10-year U.S. Treasury note — the key benchmark for U.S. government borrowing — fell over 1 basis point to 4.688%.

Oil prices were lower in early Asian trade amid hopes of a possible U.S.-Iran deal that could ease supply disruptions.

AstraZeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.

A potential deal between AstraZeneca and Bristol Myers Squibb would create a pharma giant with a combined market value of roughly $400 billion.

AstraZeneca Plc and Bristol Myers Squibb held preliminary discussions about a ​possible combination that would create one of the world's biggest pharmaceutical companies with a combined value of nearly $400 billion,

AstraZeneca declined to comment, while Bristol Myers Squibb did not immediately respond to requests for comment.

Greb Abel's Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) is shaping up to be similar to Warren Buffett's, but with the new CEO's signature decisive, bold stamp. One of the feature

The cash drag might explain why Berkshire Hathaway's Class A shares underperformed the S&P 500 index total return in the past decade. At its current market capitalization of $1.1

This is the script of CNBC's financial news report for China's CCTV on July 16, 2026. On Wednesday local time, following Warren Buffett's recent announcement that he plans to accelerate the pace of his charitable giving,

Berkshire Hathaway's new CEO tipped his hand, showing investors the kinds of changes he has in store for the giant conglomerate.